Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK. 


Biotechnology

Education

Instil Bio

Bronson Crouch

Carol Castaneda

Artur Burgiel

Craig Kessler

T. David Chonzi

Sharon McGonagle

Film Sarah Turnbull Fcipd Fitol (Goodfellow)

Sandeep Laumas (Steve)

Robert Bob Hawkins

Mark Dudley

Sandeep Laumas

The Engineering and Process Sciences Team at Instil Bio is responsible for developing and optimizing manufacturing processes for tumor infiltrating lymphocytes (TIL) therapies. This team ensures the scalability, efficiency, and compliance of production methods, supports clinical trial material production, and validates engineering processes. They play a crucial role in transitioning laboratory methods to clinical and commercial-scale manufacturing, collaborating closely with other departments to advance Instil Bio's innovative cell therapy solutions.

Engineering and Process Sciences Team

Research and Development

Board & Executive Committee

Finance Team

Engineering and Process Sciences Team

About

Team members

Other teams at Instil Bio

Research and Development

Board & Executive Committee

Finance Team